FY2025 · ended Dec 31, 2025 · Revenue $3.05B, +6.4% YoY · Filed Feb 19, 2026
UL Solutions Inc. (ULS) files with the SEC under industry code 8734, Services-Testing Laboratories. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $3.1 billion and net income of $325.0 million. Free cash flow was $403.0 million. As of Sep 30, 2026 it held $1.0 billion in cash and investments and $934.0 million in total debt.
Revenue (TTM)
$3.19B
+6.1% vs year-ago TTM
Net income (TTM)
$514.00M
+51.6% vs year-ago TTM
Operating cash flow (TTM)
$738.00M
+25.9% vs year-ago TTM
Free cash flow (TTM)
$481.00M
+23.7% vs year-ago TTM
EPS (TTM)
$2.52
+50.7% vs year-ago TTM
Dividend per share (TTM)
$0.57
+9.7% vs year-ago TTM
Shares outstanding
201.03M
+0.4% vs prior year
Net cash
$82.00M
as of Sep 30, 2026
Operating margin
17.8%
FY 2026
Company profile
- Industry
- Services-Testing Laboratories (SIC 8734)
- Listed as
- ULS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Northbrook, IL
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1901440
- Former names
- UL Solutions Inc. (until Nov 4, 2026); UL Inc. (until May 18, 2022)
Other Services-Testing Laboratories companies
- Neogenomics Inc NEO
- 20/20 Biolabs, Inc. AIDX
- Hypha Labs, Inc. FUNI
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
|---|---|---|
| Revenue | $3.1B | $2.9B |
| Operating income | $522.0M | $462.0M |
| Net income | $325.0M | $326.0M |
| Diluted EPS | $1.60 | $1.62 |
| Operating cash flow | $600.0M | $524.0M |
| Free cash flow | $403.0M | $287.0M |
| Total assets | $2.9B | $2.8B |
| Total liabilities | $1.6B | $1.9B |
| Stockholders' equity | $1.3B | $904.0M |
| Cash and investments | $295.0M | $298.0M |
| Total debt | $683.0M | $935.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 3, 2026 | Nov 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 1, 2026 | Oct 1, 2026 |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 3, 2026 | Jun 1, 2026 |
All 559 UL Solutions Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.